1[1]Murry JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection [J]. Part . Am Rev Respir Dis, 1990, 141(5):1582-1585.
3[3]Santamauro JT, Stover DE. Pneumocystis carinii pneumonia [J]. Med Clin Nor Am, 1997, 81(4):299- 301.
4[4]Evans R, Joss AW, Pennington TH, et al. Progression of Pneumocystis carinii infection in an animal model[J]. J Med Microbiol, 1998,47(6): 543 - 546.
5[5]Cere N, Polack B, Coudert P. Rabbit model of induced Pneumocystis carinii development followed by reinfection[J]. J Eukaryot Microbiol, 1997, 44(6): 21S - 23S.
6[6]Settnes OP, Settnes OP, Bille-Hansen V, et al. The piglet as a potential model of Pneumocystis carinii pneumonia[J]. J Protozool, 1991,38(6): 140S - 141S.
7[7]McFadden DC, Powles MA, Smith JG AU, et al. Use of antiCD4+ hybridoma cells to induce Pneumocystis carinii in mice [J]. Infect Immun, 1994,62(11):4887-4892.
8[8]Helweg-Larsen J, Bille-Hansen V. Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples[J] .J Clin Microbiol, 1998,36(7) 2068 - 2072.
7Chad S,Zheng MQ,Erana YG,et al.Increased host resistance against Pneumocystis carinii pneumonia in gammadelta T-cell-deficient mice:protective role of gamma interferon and CD8+ T cells[J].Infect Immun,2002,70:5208-5215.
8Kolls JK,Scott H,Shean MK,et al.INF-γ and CD8^+ restore host defenses against Pneumocystis carinii in mice depleted of CD4^+ T cells[J].J Immun,1999,162:2890-2894.
9López-Palomo C,Martín-Zamorano M,Benítez E,et al.Pneumonia in HIV-infected patients in the HAART era:Incidence,risk,and impact of the pneumococcal vaccination[J].J Med Virol,2004,72:517-524.
10Powles T,Imami N,Nelson M,et al.Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma[J].AIDS,2002,16:531-536.
